Europe · News · Reuters
Glaukos says late-stage eye disease treatment shows lasting benefits after single dose
Glaukos said on Wednesday patients treated with its late-stage eye disease therapy maintained improvements in vision and corneal shape three years after a single treatment for…
Read the full article on Reuters Sign in to saveMediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.reuters.com)





